Literature DB >> 25968158

Mitochondrial tRNA(Ser(UCN)) variants in 2651 Han Chinese subjects with hearing loss.

Xiaowen Tang1, Jing Zheng2, Zhengbiao Ying3, Zhaoyang Cai3, Yinglong Gao1, Zheyun He1, Han Yu1, Juan Yao1, Yaling Yang1, Hui Wang1, Ye Chen2, Min-Xin Guan4.   

Abstract

Mutations in the mitochondrial DNA have been associated with hearing loss. However, the prevalence and spectrum of mitochondrial tRNA mutations in hearing-impaired subjects are poorly understood. In this report, we have investigated the prevalence and spectrum of mitochondrial tRNA(Ser(UCN)) mutations in a large cohort of 2651 Han Chinese subjects with hearing loss. The clinical evaluation showed that 744 subjects (432 males and 312 females) had a history of exposure to aminoglycosides and other probands exhibited nonsyndromic hearing loss. Mutational analysis of tRNA(Ser(UCN)) gene identified 9 (8 known and 1 novel) variants. The prevalence of the known deafness-associated 7511T>C, 7505T>C and 7445A>C mutations was 0.04%, 0.04% and 0.04%, respectively. Other variants were evaluated by the evolutionary conservation, allelic frequency of Chinese controls, potential structural and functional alterations and pedigree analysis. Three variants were polymorphisms, while the 7444G>A, 7471DelG and 7496A>G variants were putative deafness-associated mutations. These putative deafness-associated variants accounted for 0.68% cases of hearing-impaired subjects in this cohort. The low penetrance of hearing loss in pedigrees carrying one of these putative deafness-associated mutations indicated that the mutation(s) is necessary but itself insufficient to produce a clinical phenotype. Other genetic or environmental factor(s) may influence the phenotypic manifestation of these tRNA(Ser(UCN)) mutations. Moreover, mtDNAs in 20 probands carrying one of the putative deafness-associated mutations were widely dispersed among 8 Eastern Asian haplogroups. In particular, the occurrences of haplogroups D4a, M22, and H2 in patients carrying the deafness-associated variants were higher than those in Chinese controls. These data further support that the mitochondrial tRNA(Ser(UCN)) gene is the hot spot for mutations associated with hearing loss. Thus, our findings may provide valuable information for the further understanding of pathophysiology and management of hearing loss.
Copyright © 2015 Elsevier B.V. and Mitochondria Research Society. All rights reserved.

Entities:  

Keywords:  Hearing loss; Incidence; Mitochondria; Mutation; Spectrum; tRNA

Mesh:

Substances:

Year:  2015        PMID: 25968158     DOI: 10.1016/j.mito.2015.05.001

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  10 in total

1.  Biochemical Evidence for a Nuclear Modifier Allele (A10S) in TRMU (Methylaminomethyl-2-thiouridylate-methyltransferase) Related to Mitochondrial tRNA Modification in the Phenotypic Manifestation of Deafness-associated 12S rRNA Mutation.

Authors:  Feilong Meng; Xiaohui Cang; Yanyan Peng; Ronghua Li; Zhengyue Zhang; Fushan Li; Qingqing Fan; Anna S Guan; Nathan Fischel-Ghosian; Xiaoli Zhao; Min-Xin Guan
Journal:  J Biol Chem       Date:  2017-01-03       Impact factor: 5.157

2.  Contribution of a mitochondrial tyrosyl-tRNA synthetase mutation to the phenotypic expression of the deafness-associated tRNASer(UCN) 7511A>G mutation.

Authors:  Wenlu Fan; Jing Zheng; Wanzhong Kong; Limei Cui; Maerhaba Aishanjiang; Qiuzi Yi; Min Wang; Xiaohui Cang; Xiaowen Tang; Ye Chen; Jun Qin Mo; Neal Sondheimer; Wanzhong Ge; Min-Xin Guan
Journal:  J Biol Chem       Date:  2019-11-04       Impact factor: 5.157

3.  Contribution of the tRNAIle 4317A→G mutation to the phenotypic manifestation of the deafness-associated mitochondrial 12S rRNA 1555A→G mutation.

Authors:  Feilong Meng; Zheyun He; Xiaowen Tang; Jing Zheng; Xiaofen Jin; Yi Zhu; Xiaoyan Ren; Mi Zhou; Meng Wang; Shasha Gong; Jun Qin Mo; Qiang Shu; Min-Xin Guan
Journal:  J Biol Chem       Date:  2018-01-18       Impact factor: 5.157

4.  A Deafness- and Diabetes-associated tRNA Mutation Causes Deficient Pseudouridinylation at Position 55 in tRNAGlu and Mitochondrial Dysfunction.

Authors:  Meng Wang; Hao Liu; Jing Zheng; Bobei Chen; Mi Zhou; Wenlu Fan; Hen Wang; Xiaoyang Liang; Xiaolong Zhou; Gilbert Eriani; Pingping Jiang; Min-Xin Guan
Journal:  J Biol Chem       Date:  2016-08-12       Impact factor: 5.157

5.  A deafness-associated tRNAAsp mutation alters the m1G37 modification, aminoacylation and stability of tRNAAsp and mitochondrial function.

Authors:  Meng Wang; Yanyan Peng; Jing Zheng; Binjiao Zheng; Xiaofen Jin; Hao Liu; Yong Wang; Xiaowen Tang; Taosheng Huang; Pingping Jiang; Min-Xin Guan
Journal:  Nucleic Acids Res       Date:  2016-08-17       Impact factor: 16.971

6.  Application of next‑generation sequencing to identify mitochondrial mutations: Study on m.7511T>C in patients with hearing loss.

Authors:  Urszula Lechowicz; Agnieszka Pollak; Agnieszka Frączak; Małgorzata Rydzanicz; Piotr Stawiński; Artur Lorens; Piotr H Skarżyński; Henryk Skarżyński; Rafał Płoski; Monika Ołdak
Journal:  Mol Med Rep       Date:  2017-11-15       Impact factor: 2.952

7.  Mitochondrial tRNA mutations in Chinese Children with Tic Disorders.

Authors:  Peifang Jiang; Yinjie Ling; Tao Zhu; Xiaoying Luo; Yilin Tao; Feilong Meng; Weixin Cheng; Yanchun Ji
Journal:  Biosci Rep       Date:  2020-12-08       Impact factor: 3.840

8.  Novel m.4268T>C mutation in the mitochondrial tRNAIle gene is associated with hearing loss in two Chinese families.

Authors:  Li-Jing Zhao; Zhi-Li Zhang; Yong Fu
Journal:  World J Clin Cases       Date:  2022-01-07       Impact factor: 1.337

9.  Maternally transmitted nonsyndromic hearing impairment may be associated with mitochondrial tRNAAla 5601C>T and tRNALeu(CUN) 12311T>C mutations.

Authors:  Xuejiao Yu; Sheng Li; Yu Ding
Journal:  J Clin Lab Anal       Date:  2022-02-26       Impact factor: 2.352

10.  Low penetrance of hearing loss in two Chinese families carrying the mitochondrial tRNASer(UCN) mutations.

Authors:  Wei Peng; Yi Zhong; Xueyan Zhao; Jie Yuan
Journal:  Mol Med Rep       Date:  2020-04-30       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.